These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3508061)

  • 21. Hypothermic total body washout and intracranial pressure monitoring in Stage IV Reye syndrome.
    Lansky LL; Kalavsky SM; Brackett CE; Wallas CH; Reis RL
    J Pediatr; 1977 Apr; 90(4):639-40. PubMed ID: 839385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carnitine prevents Reye-like syndrome in atypical carnitine deficiency.
    Matsubasa T; Ohtani Y; Miike T; Kitano A; Endo F; Matsuda I
    Pediatr Neurol; 1986; 2(2):80-4. PubMed ID: 3508683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reye syndrome: results of intensive supportive care.
    DeVivo DC; Keating JP; Haymond MW
    J Pediatr; 1975 Dec; 87(6 Pt 1):875-80. PubMed ID: 1185388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased serum carnitine in valproate induced Reye syndrome.
    Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
    Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in serum glucose and hepatic glycogen concentrations during octanoate administration in rabbits.
    Trice JE; Trauner DA
    Pediatr Neurol; 1985; 1(5):294-7. PubMed ID: 3880415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring and management of increased intracranial pressure in Reye syndrome: results in 29 children.
    Shaywitz BA; Rothstein P; Venes JL
    Pediatrics; 1980 Aug; 66(2):198-204. PubMed ID: 6773021
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of increasing carbon chain length on organic acid transport by the choroid plexus: a potential factor in Reye's syndrome.
    Kim CS; O'Tuama LA; Mann JD; Roe CR
    Brain Res; 1983 Jan; 259(2):340-3. PubMed ID: 6402269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reye syndrome associated with aspirin therapy for systemic lupus erythematosus.
    Hansen JR; McCray PB; Bale JF; Corbett AJ; Flanders DJ
    Pediatrics; 1985 Aug; 76(2):202-5. PubMed ID: 4022693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury--Results From an Automated Data Collection System Time-Synched to Drug Administration.
    Shein SL; Ferguson NM; Kochanek PM; Bayir H; Clark RS; Fink EL; Tyler-Kabara EC; Wisniewski SR; Tian Y; Balasubramani GK; Bell MJ
    Pediatr Crit Care Med; 2016 Mar; 17(3):236-45. PubMed ID: 26673840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chain length of short-chain fatty acids on their effect on intracranial pressure in rabbits.
    Trauner DA; Adams H
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):428-30. PubMed ID: 6806449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic response to hypertonic glucose administration in Reye syndrome.
    Haymond MW; Karl IE; Keating JP; DeVivo DC
    Ann Neurol; 1978 Mar; 3(3):207-15. PubMed ID: 666261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial pressure monitoring in Reye-Johnson syndrome.
    Mickell J; Cook DR; Reigel DH; Painter MJ; Safar P
    Crit Care Med; 1976; 4(1):1-7. PubMed ID: 1253611
    [No Abstract]   [Full Text] [Related]  

  • 34. REYE (RAY'S) SYNDROME: A PROBLEM EVERYONE SHOULD REMEMBER.
    Chornomydz I; Boyarchuk O; Chornomydz A
    Georgian Med News; 2017 Nov; (272):110-118. PubMed ID: 29227269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency.
    Bzduch V; Behulova D; Salingova A; Ponec J; Fabriciova K; Kozak L
    Bratisl Lek Listy; 2003; 104(12):405-7. PubMed ID: 15053333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical care and anesthetic management of Reye's syndrome.
    Hubbert CH
    South Med J; 1979 Jun; 72(6):684-6. PubMed ID: 451652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy for Reye's syndrome.
    Mutchie KD; Burckart GJ
    Am J Hosp Pharm; 1979 Jun; 36(6):767-73. PubMed ID: 463892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon.
    Ulrich RG; Bacon JA; Brass EP; Cramer CT; Petrella DK; Sun EL
    Chem Biol Interact; 2001 May; 134(3):251-70. PubMed ID: 11336974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute dimethyl sulfoxide therapy in experimental brain edema: Part I. Effects on intracranial pressure, blood pressure, central venous pressure, and brain water and electrolyte content.
    Camp PE; James HE; Werner R
    Neurosurgery; 1981 Jul; 9(1):28-33. PubMed ID: 7279169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain resuscitation in metabolic-toxic infectious encephalopathy.
    Safar P
    Crit Care Med; 1978; 6(1):68-70. PubMed ID: 639535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.